Nose surgery.
Conditions
Interventions
Intervention 1: 3 tablets a day from first to the third day and 2 tablets a day from the fourth day to the seventh day after the surgery. Intervention 2: Control group: Patients in the anahil drug con
Sponsors
Zahedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Having full conscious content of research goals, patients aged between 18-40 without having any migraine, diabetes, kidney, cardiovascular, or pulmonary disease before having any surgery who were nominated for Raynoplasti, started the study.
Exclusion criteria
Exclusion criteria: There were breaches in each of the Word criteria.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Anahil medicine. Timepoint: 3 tablets a day from first to the third day and 2 tablets a day from the fourth day to the seventh day after the surgery. Method of measurement: Examination by a specialist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Gholam Ali Dashti Khoidaki
Zahedan University of Medical Sciences
Outcome results
None listed